SCHEMBL2463873

SCHEMBL2463873

CC(c1c(C(N)=O)ccc(C(N)=O)c1N)N1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
AAK1 Q2M2I8 1/20 0.38
KDM4E B2RXH2 1/20 0.36
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.35
AURKA O14965 1/20 0.34
RPS6KB1 P23443 1/20 0.34
LRRK2 Q5S007 1/20 0.34
ALOX15 P16050 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18108807 0.83 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4CYP2C19AAK1
SCHEMBL18108809 0.81 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4CYP2C19AAK1
SCHEMBL16176806 0.81 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4CYP2C19AAK1
SCHEMBL16463458 0.75 ALDH1A1 (0.47) ALDH1A1TSHRCYP3A4CYP2C19KDM4E
SCHEMBL19949448 0.73 ATR (0.47) ALDH1A1TSHRCYP3A4CYP2C19AAK1
SCHEMBL13163125 0.72 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4CYP2C19KMT2A
SCHEMBL263757 0.72 ALDH1A1 (0.49) ALDH1A1TSHRCYP3A4CYP2C19KMT2A
SCHEMBL16462026 0.71 ALDH1A1 (0.43) ALDH1A1TSHRCYP3A4CYP2C19KDM4E
SCHEMBL19949449 0.70 ATR (0.45) ALDH1A1TSHRCYP3A4CYP2C19AAK1
SCHEMBL2466382 0.67 IRAK4 (0.35) ALDH1A1TSHRKDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US claimed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 ALDH1A1 323/4885TSHR 172/4885MKNK1 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.